InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Deschatelets Pascal, Chief Scientific Officer. Insider active across 2 companies, notably Apellis Pharmaceuticals, Inc.. In total, 14 reports have been published. The latest transaction was filed on 17 June 2022 — Levée d'options. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations14 total
1,177,222 shares
Common Stock
SEC:0001193125-26-224609·
1,177,222 shares
Common Stock
SEC:0001193125-26-224609:0·
€83,55433,005 shares@ €2.53160.0016% mcap30.2% of flow
Common Stock
SEC:0001127602-22-017991:0·
€29,89512,000 shares@ €2.49120.0006% mcap10.8% of flow
Common Stock
SEC:0001127602-22-017181:0·
01,875 shares0
Common Stock
SEC:0001127602-22-012929:0·
€43,6071,057 shares@ €41.25540.0008% mcap15.8% of flow
Common Stock
SEC:0001127602-22-004826:0·
€32,230931 shares@ €34.61910.0006% mcap53.8% of flow
Common Stock
SEC:0001127602-22-002807·
€32,230931 shares@ €34.61910.0006% mcap11.6% of flow
Common Stock
SEC:0001127602-22-002807:0·
026,051 shares0
Common Stock
SEC:0001127602-22-002066·
026,051 shares0
Common Stock
SEC:0001127602-22-002066:0·
€13,9876,250 shares@ €2.2380.0003% mcap23.4% of flow
Common Stock
SEC:0001127602-21-020710·
€13,9876,250 shares@ €2.2380.0003% mcap5.1% of flow
Common Stock
SEC:0001127602-21-020710:0·
€13,6626,250 shares@ €2.18590.0003% mcap22.8% of flow
Common Stock
SEC:0001127602-21-017979·
€13,6626,250 shares@ €2.18590.0003% mcap4.9% of flow
Common Stock
SEC:0001127602-21-017979:0·
14 of 14 declarations
About Deschatelets Pascal
Pascal Deschatelets is the Chief Scientific Officer at Apellis Pharmaceuticals, Inc. In this role, he is responsible for the research and development of new treatments. His scientific expertise is essential for innovation and product development within Apellis.
